Small and Large Bowel Transit Tests Using MRI (Study 1)
NCT01534507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108
Last updated 2014-08-13
Summary
Irritable bowel syndrome, (IBS) is a common functional disorder of the gut that can be quite disabling to patients. The most common symptoms of IBS are abdominal pain or discomfort along with erratic changes in bowel habit of diarrhoea, constipation or a mixture of the two (referred to as IBS subtypes). Despite much research efforts to further understand the pathophysiology of IBS; as yet no specific biomarkers/definitive measurements have been identified that can be use to aid the diagnosis and reduce the need for unnecessary, unpleasant and expensive tests.
Evidence shows that anxiety plays a part in IBS and can speed up transit time in the small bowel. In this study, the investigators hypothesise that since anxiety is a common feature of IBS, then fast small bowel transit is likely to be found in all subtypes of IBS and the difference in stool frequency and consistency in IBS subgroups are therefore likely to reflect differences in colonic function. The investigator wish to test this by measuring both small and large bowel transit times using Magnetic Resonance Imaging (MRI) and validate the results of the MRI with two methods currently used in clinical practice -The previously validated lactose-C13 Ureide breath test (for small bowel transit) and the standard radio-opaque pellet method to assess the whole gut transit (WGT) time.
Conditions
- Irritable Bowel Syndrome
Sponsors & Collaborators
-
University of Nottingham
lead OTHER
Principal Investigators
-
Robin Spiller, MD FRCP · University of Nottingham
-
Ching Lam, MBchB MRCP · University of Nottingham
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2014-08-31
- Completion
- 2014-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Understanding Abdominal Pain in IBD and IBS
NCT04020835 ·Status: UNKNOWN
-
The Value of Bio-electrical Impedance Analysis in Irritable Bowel Syndrome
NCT05744258 ·Status: COMPLETED ·Phase: NA
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Fructose and Fructans in Irritabla Bowel Syndrome
NCT01776853 ·Status: COMPLETED ·Phase: NA
-
Early Signs of Parkinsons Disease in IBS
NCT05573542 ·Status: ENROLLING_BY_INVITATION
-
Investigation of Acupoint in Irritable Bowel Syndrome Based on Biological Characteristics
NCT06365801 ·Status: NOT_YET_RECRUITING
-
Investigating the Gut Microbiome and Symptomology in IBS
NCT06708533 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
Assessment of Small Intestinal Bowel Epithelial Gaps in Irritable Bowel Syndrome
NCT01632488 ·Status: UNKNOWN
-
Diet and Motility in IBS
NCT07283341 ·Status: RECRUITING
-
Neurotrophic Factors, Tight Junction Proteins, and Cytokines in IBS
NCT03675100 ·Status: COMPLETED ·Phase: NA
-
Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China
NCT02955316 ·Status: COMPLETED
-
A Clinical Trial Evaluating Diets for IBS
NCT05831306 ·Status: UNKNOWN ·Phase: NA
-
"Functional Bowel Disorder. Investigation in General Practice"
NCT01153295 ·Status: COMPLETED ·Phase: NA
-
A Cross-sectional Study on IBS Subtypes, Chinese Medicine Pattern and Host-gut Microbiota Metabolic Interactions
NCT02822677 ·Status: COMPLETED
-
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
NCT01072903 ·Status: COMPLETED
-
Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome.
NCT01297556 ·Status: UNKNOWN ·Phase: NA
-
Irritable Bowel Syndrome Regional Cohort
NCT06900491 ·Status: RECRUITING
-
Microbiota Profiling in IBS
NCT03720314 ·Status: COMPLETED
-
Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With Desipramine
NCT00880594 ·Status: TERMINATED ·Phase: NA
-
Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
NCT02981888 ·Status: COMPLETED
-
The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D
NCT06543498 ·Status: COMPLETED ·Phase: NA
-
Abdominal Symptom Phenotype Study in Children
NCT01204515 ·Status: COMPLETED
-
FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment
NCT03125564 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Intestinal Parasitic Infections in Patients With Irritable Bowel Syndrome
NCT05830370 ·Status: UNKNOWN